Vivo Capital, LLC Diversified Active

CIK: 0001674712 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 12, 2025

Total Value ($000): $755,066 (100.0% shares, 0.0% debt)

Holdings (40)

SLNO Soleno Therapeutics Inc 42.2%
Value ($000) $318,545 Shares 4,458,294 Est. Cost $19.93 Unrealized +144.3%
Verona Pharma PLC 12.1%
Value ($000) $91,348 Shares 1,438,785 Est. Cost $6.97 Unrealized
GERN Geron Corp 5.7%
Value ($000) $43,288 Shares 27,225,292 Est. Cost $1.62 Unrealized +50.6%
TRVI Trevi Therapeutics Inc 2.9%
Value ($000) $21,939 Shares 3,487,903 Est. Cost $3.10 Unrealized +54.1%
Avadel Pharmaceuticals PLC 2.8%
Value ($000) $21,017 Shares 2,684,109 Est. Cost $13.12 Unrealized
TERN Terns Pharmaceuticals Inc 2.5%
Value ($000) $19,032 Shares 6,895,746 Est. Cost $11.04 Unrealized -63.0%
Cidara Therapeutics, Inc. 2.0%
Value ($000) $14,739 Shares 684,276 Est. Cost $26.77 Unrealized
ACRS Aclaris Therapeutics, Inc. 1.8%
Value ($000) $13,600 Shares 8,888,888 Est. Cost $2.49 Unrealized -14.3%
VRDN Viridian Therapeutics Inc 1.8%
Value ($000) $13,245 Shares 982,576 Est. Cost $15.47 Unrealized +10.1%
DYN Dyne Therapeutics Inc 1.5%
Value ($000) $11,662 Shares 1,114,960 Est. Cost $18.65 Unrealized -23.3%
ORIC Oric Pharmaceuticals Inc 1.5%
Value ($000) $11,609 Shares 2,080,450 Est. Cost $8.53 Unrealized +2.5%
TIL Instil Bio Inc 1.3%
Value ($000) $10,164 Shares 585,485 Est. Cost $7.23 Unrealized +186.7%
CMPS Compass Pathway PLC 1.3%
Value ($000) $9,616 Shares 3,362,385 Est. Cost $5.03 Unrealized
DCTH Delcath Systems, Inc. 1.3%
Value ($000) $9,550 Shares 750,195 Est. Cost $7.32 Unrealized +93.8%
ZBIO Zenas Biopharma Inc 1.2%
Value ($000) $9,348 Shares 1,183,260 Est. Cost $17.98 Unrealized -56.5%
VSTM Verastem Inc 1.2%
Value ($000) $9,277 Shares 1,538,461 Est. Cost $6.94 Unrealized -12.0%
ERAS Erasca Inc 1.2%
Value ($000) $9,257 Shares 6,756,756 Est. Cost $2.16 Unrealized -20.5%
DRUG Bright Minds Biosciences Inc 1.2%
Value ($000) $9,074 Shares 251,572 Est. Cost $35.19 Unrealized +4.0%
Tourmaline Bio Inc. 1.2%
Value ($000) $9,003 Shares 591,882 Est. Cost $26.18 Unrealized
ABEO Abeona Therapeutics, Inc. 1.2%
Value ($000) $8,771 Shares 1,842,751 Est. Cost $5.10 Unrealized +6.6%
Astria Therapeutics Inc 1.1%
Value ($000) $8,291 Shares 1,552,685 Est. Cost $6.12 Unrealized
Akero Therapeutics Inc 1.1%
Value ($000) $8,143 Shares 201,168 Est. Cost $40.48 Unrealized
CRVS Corvus Pharmaceuticals Holdings 0.9%
Value ($000) $7,106 Shares 2,234,566 Est. Cost $4.87 Unrealized -3.3%
CMPX Compass Therapeutics Inc 0.9%
Value ($000) $6,756 Shares 3,556,023 Est. Cost $3.60 Unrealized -26.0%
IOBT IO Biotech Inc 0.9%
Value ($000) $6,729 Shares 6,173,439 Est. Cost $5.62 Unrealized -83.2%
COGT Cogent Biosciences Inc 0.9%
Value ($000) $6,724 Shares 1,122,471 Est. Cost $8.55 Unrealized -8.3%
Unicycive Therapeutics 0.9%
Value ($000) $6,537 Shares 11,370,152 Est. Cost $0.75 Unrealized
CELC Celcuity Inc 0.8%
Value ($000) $6,172 Shares 610,500 Est. Cost $16.73 Unrealized -32.4%
RZLT Rezolute Inc 0.8%
Value ($000) $6,126 Shares 2,112,432 Est. Cost $1.28 Unrealized +241.2%
SERA Sera Prognostics Inc 0.8%
Value ($000) $6,074 Shares 1,650,440 Est. Cost $10.38 Unrealized -50.9%
OLMA Olema Pharmaceuticals Inc 0.7%
Value ($000) $5,662 Shares 1,505,862 Est. Cost $31.43 Unrealized -84.0%
Regulus Therapeutics Inc 0.6%
Value ($000) $4,719 Shares 2,696,426 Est. Cost $2.88 Unrealized
SLN Silence Therapeutics PLC 0.4%
Value ($000) $3,117 Shares 1,105,454 Est. Cost $19.65 Unrealized
SRZN Surrozen Inc 0.4%
Value ($000) $3,032 Shares 260,000 Est. Cost $11.62 Unrealized 0.0%
89Bio Inc 0.4%
Value ($000) $2,739 Shares 376,804 Est. Cost $7.27 Unrealized
Bolt Therapeutics Inc 0.2%
Value ($000) $1,409 Shares 3,521,291 Est. Cost $32.91 Unrealized
TENX Tenax Therapeutics Inc 0.2%
Value ($000) $1,365 Shares 208,333 Est. Cost $3.62 Unrealized +77.1%
Allakos Inc 0.0%
Value ($000) $174 Shares 765,500 Est. Cost $6.12 Unrealized
ALGS Aligos Therapeutics Inc 0.0%
Value ($000) $84 Shares 10,199 Est. Cost $12.44 Unrealized +76.2%
DTIL Precision Biosciences Inc 0.0%
Value ($000) $22 Shares 4,675 Est. Cost $12.24 Unrealized -58.4%